“Liver is diffusely low in attenuation” is radiology language for a liver that looks darker than expected on a CT scan, spread evenly across the organ rather than in patches. In the vast majority of cases, it means fat has accumulated inside liver cells. The finding is common, usually incidental, and almost always points to some degree of fatty liver disease. But the phrase itself is descriptive, not a diagnosis, and understanding what comes next matters more than the finding alone.
What “Low Attenuation” Actually Means on a CT Scan
CT scanners measure how dense different tissues are by tracking how much they absorb (or “attenuate”) an X-ray beam. The result is reported in Hounsfield units (HU). Water sits at 0 HU, bone is up around 1,000 HU, and a healthy liver typically measures somewhere around 55 to 65 HU. In a large study of over 3,300 asymptomatic adults, the average liver attenuation was about 59 HU.1PubMed. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT Fat, by contrast, has very low density and pulls the HU number down. When enough fat accumulates in the liver, the whole organ shifts darker on the scan.
Radiologists often compare the liver’s brightness to the spleen’s, since the two organs normally look similar on CT. A liver that measures noticeably less dense than the spleen raises a flag. Specific thresholds vary, but liver attenuation below about 40 to 45 HU on an unenhanced scan, or a liver-to-spleen difference below roughly 0 to minus 5 HU, is highly specific for at least moderate fat accumulation.2PubMed. Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis “Diffusely” means the low attenuation is spread throughout the liver rather than concentrated in one lobe or segment, which is the typical pattern for metabolic fatty liver disease.
Fatty Liver Disease Is the Overwhelming Cause
When a radiologist writes this phrase on your report, fatty liver disease is by far the most likely explanation. Non-alcoholic fatty liver disease (NAFLD) is the most common diffuse liver condition worldwide, estimated to affect roughly 20 to 46 percent of the global population.3PubMed Central. Current status of imaging in nonalcoholic fatty liver disease That range is wide because prevalence depends heavily on how you define it, the population studied, and the imaging method used. In the Multi-Ethnic Study of Atherosclerosis, about 17 percent of participants met CT criteria for fatty liver using a moderate threshold, and roughly 6 percent had severe enough fat accumulation that liver density dropped below 40 HU.4PubMed Central. Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study: The Multi-Ethnic Study of Atherosclerosis
The risk factors are familiar: being overweight, having high blood sugar, abnormal cholesterol levels, or high blood pressure. In that same study, fatty liver was present in more than 70 percent of participants with abnormal lipid levels and over half of those who were obese.4PubMed Central. Computed Tomography Scans in the Evaluation of Fatty Liver Disease in a Population Based Study: The Multi-Ethnic Study of Atherosclerosis Diabetes carries its own elevated risk. Being overweight turns out to be a sensitive but non-specific marker: over 90 percent of people with moderate-to-severe fatty liver had a BMI above 25, but plenty of overweight people have no significant liver fat at all.1PubMed. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT
NAFLD itself spans a spectrum. Most people have simple steatosis, where fat sits in the liver without causing much inflammation or damage. A smaller proportion develop nonalcoholic steatohepatitis (NASH), where inflammation and cell injury are present, potentially leading to scarring and eventually cirrhosis.5PubMed Central. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging A CT scan cannot tell you which end of that spectrum you are on. It can show fat is there, but it cannot see inflammation or early scarring.
Other Causes Beyond Metabolic Fatty Liver
Although NAFLD dominates, alcohol-related liver disease produces the same imaging appearance. The spectrum of alcohol-associated liver disease includes steatosis as its most common manifestation, along with steatohepatitis and, in advanced cases, cirrhosis.6PubMed Central. Imaging of Alcohol-Associated Liver Disease Your doctor will ask about drinking habits to distinguish the two. Clinically, the approach differs because alcohol cessation is the cornerstone of treatment for alcohol-related disease, whereas metabolic management drives the approach for NAFLD.
Certain medications can also push fat into the liver. Drug-induced fatty liver disease is a recognized contributor to liver injury, and a range of commonly prescribed drugs have been linked to it, including corticosteroids, certain chemotherapy agents, amiodarone, tamoxifen, and some antiretrovirals.7PubMed Central. Drug-induced Fatty Liver Disease: Pathogenesis and Treatment If a new medication coincides with the CT finding, that connection is worth flagging to your doctor.
Rarer causes exist too. Acute fatty liver of pregnancy is an uncommon but serious condition that can produce the same low-attenuation appearance on CT.8American Journal of Obstetrics and Gynecology. Computed tomography in acute fatty liver of pregnancy Certain inherited metabolic conditions also alter liver density. In glycogen storage disease, for example, the simultaneous presence of fat and glycogen in the liver can produce a wide range of CT densities, from very low to abnormally high, depending on the relative amounts of each.9PubMed. Computed tomography of the liver and kidneys in glycogen storage disease These conditions are uncommon and usually diagnosed in childhood, but hepatic glycogenosis can also develop secondarily in adults with poorly controlled diabetes.10PubMed. Computed Tomography and Magnetic Resonance Imaging Features of Primary and Secondary Hepatic Glycogenosis
How Reliable Is This Finding
CT is quite good at ruling in fatty liver when fat content is substantial, but it is not equally good at all severity levels. A meta-analysis comparing imaging methods against liver biopsy found that CT had sensitivity in the range of 46 to 72 percent (depending on the threshold of steatosis) but specificity of 88 to 95 percent.11PubMed Central. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis In plain terms, if the CT says the liver looks fatty, it almost certainly is. But if the CT looks normal, that does not guarantee the liver is fat-free, because mild steatosis often flies under CT’s radar.
One reason for that gap is that the threshold for calling the liver “low in attenuation” is typically set at levels that correspond to moderate or severe fat accumulation. At liver attenuation below 40 HU on unenhanced CT, you are looking at roughly 30 percent or more fat content. Milder degrees of steatosis, where perhaps 5 to 15 percent of liver cells contain fat droplets, may not push the HU numbers low enough to trigger the finding. CT is a blunt instrument for mild disease but a confident one for moderate-to-severe disease.
Why the Type of CT Scan Matters
Not every CT scan is created equal when it comes to measuring liver density. The distinction between unenhanced (no contrast dye) and contrast-enhanced scans matters a lot. When iodine-based contrast dye is injected, it raises the attenuation of all blood-rich organs including the liver and spleen, but not by the same amount or at the same time. This makes the raw HU numbers harder to interpret for fat detection.
On an unenhanced scan, liver attenuation tracks linearly with actual fat content, which makes interpretation straightforward.12PubMed. Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1204 Healthy Adults Using Unenhanced CT as a Reference Standard On contrast-enhanced scans, the picture gets murkier. Recent research suggests that liver attenuation below 90 HU on a contrast-enhanced portal venous phase scan correctly identified steatosis in about 97 percent of cases, and that portal venous liver HU alone actually outperformed the traditional liver-minus-spleen calculation for spotting moderate steatosis.13PubMed. Post-contrast CT liver attenuation alone is superior to the liver-spleen difference for identifying moderate hepatic steatosis Still, unenhanced CT remains more reliable overall. In clinical practice, the scan you received was probably done for some other reason (evaluating abdominal pain, screening, staging a condition), so the radiologist works with whichever type of scan was ordered.
This is a practical point: if your CT was done with contrast for, say, kidney stones or a cancer check, and the report mentions low liver attenuation, your doctor may be slightly less certain about the degree of fat than they would be from an unenhanced scan. It does not mean the finding is wrong, but the quantitative precision is lower.
What Typically Happens After This Shows Up on Your Report
Most people who see this phrase on a CT report were not being scanned for liver problems in the first place. The CT was ordered for something else, and the fatty liver was noticed along the way. Radiologists have suggested that incidentally reported fatty liver should prompt consideration of clinical follow-up and lipid panel testing even in people who feel perfectly fine.14European Journal of Gastroenterology & Hepatology. Comparison of correlations between lipid profile and different computed tomography fatty liver criteria in the setting of incidentally noted fatty liver on computed tomography examinations
Your doctor will likely check blood work including liver enzymes (ALT and AST), blood sugar, and a lipid panel.15European Journal of Gastroenterology & Hepatology. Comparison of computed tomography hepatic steatosis criteria for identification of abnormal liver function and clinical risk factors, in incidentally noted fatty liver Normal liver enzymes do not rule out fatty liver, but elevated enzymes raise concern that inflammation (steatohepatitis) may be developing. The blood tests also help identify the metabolic conditions, like insulin resistance or high triglycerides, that are likely driving the fat accumulation.
A liver biopsy remains the definitive way to assess not just how much fat is present, but whether there is inflammation, cell damage, or fibrosis. However, biopsy is invasive, carries a small but real risk of complications, and is subject to sampling error because only a tiny sliver of the organ is examined.16PubMed Central. Noninvasive assessment of hepatic steatosis For that reason, biopsy is not the first step for most people with an incidental finding of fatty liver on CT. It is reserved for situations where the clinical picture is concerning enough to warrant it, like persistently abnormal liver enzymes or signs that the disease may be progressing.
When Additional Imaging Is Ordered
If your doctor wants a more precise measure of liver fat or needs to check for fibrosis without a biopsy, they have several options. MRI with proton density fat fraction (PDFF) measurement has become the leading non-invasive reference standard for quantifying liver fat. It correlates strongly with biopsy-confirmed fat content and is especially good at detecting mild steatosis that CT misses.17Medical Research Archives. A prospective technical validation study comparing Proton Density Fat Fraction by MRI and Liver Attenuation Index by CT for the quantitative assessment of hepatic steatosis in living liver donors with histopathological correlation as standard reference In a study of liver donors, MRI-PDFF achieved near-perfect diagnostic accuracy for detecting steatosis, far outperforming CT-based measurements.18PubMed. Liver Fat Content Measurement with Quantitative CT Validated against MRI Proton Density Fat Fraction: A Prospective Study of 400 Healthy Volunteers
FibroScan, a specialized ultrasound device, offers another non-invasive option. It uses transient elastography to assess liver stiffness (a proxy for fibrosis) and a feature called controlled attenuation parameter (CAP) to estimate fat content. It has shown good accuracy in grading steatosis and staging fibrosis in NAFLD patients, and it is particularly useful for identifying people who do not have advanced fibrosis and therefore do not need a biopsy.19PubMed Central. Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease – Where do we stand? FibroScan is faster, cheaper, and more widely available than MRI, which makes it a practical choice for ongoing monitoring.
Newer CT technologies are also improving. Dual-energy CT can generate “virtual non-contrast” images from a contrast-enhanced scan, potentially allowing fat assessment even when the scan was done with contrast dye. Early results show that attenuation measured on virtual non-contrast images correlates moderately with liver fat content and has greater than 90 percent specificity for diagnosing fatty liver.20PubMed Central. Detection of fatty liver using virtual non-contrast dual-energy CT This technology is not yet standard everywhere, but it suggests that future CT scans may be able to do double duty: addressing whatever clinical question prompted the scan while also reliably flagging liver fat.
Can Fatty Liver Be Reversed
Here is the reassuring part of this story: fatty liver, particularly simple steatosis, responds well to lifestyle changes. Weight loss is the single most effective intervention. In studies of people with NAFLD, those who lost 10 percent or more of their body weight saw near-universal improvements in liver histology, with 90 percent showing resolution of steatohepatitis and 45 percent showing regression of fibrosis.21PubMed Central. Nonalcoholic Fatty Liver Disease and Obesity Treatment The catch is that only about 10 percent of participants in that particular study actually achieved that degree of weight loss. More modest weight loss, in the range of 4 to 10 percent, still consistently improved liver fat levels and liver enzyme numbers across multiple studies.21PubMed Central. Nonalcoholic Fatty Liver Disease and Obesity Treatment
Exercise appears to help independently of weight loss. A meta-analysis of lifestyle intervention trials found that physical activity improved liver fat and liver enzyme levels even when body weight did not change significantly.22PubMed. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis The mechanism likely involves changes in how the liver handles fat metabolism that go beyond simply burning calories.
These improvements show up on imaging. In one of the earliest studies tracking this, researchers put patients with obesity-related fatty liver on a calorie-restricted diet and repeated CT scans after three months. Liver attenuation values rose as fat content dropped, and liver enzyme levels fell in parallel.23PubMed. Obesity-related nonalcoholic fatty liver: CT features and follow-up studies after low-calorie diet This means that the same CT finding that flagged the problem can, in principle, be used to confirm it is getting better, though in practice your doctor is more likely to track progress with blood tests or ultrasound than with repeat CT scans, given the radiation exposure.
Why the Finding Should Not Be Ignored but Also Should Not Panic You
Fatty liver sits in an awkward clinical space. For most people, simple steatosis is benign and reversible. But NAFLD is also linked to a higher risk of cardiovascular disease and type 2 diabetes, and the progressive form, NASH, can quietly advance to cirrhosis over years or decades.5PubMed Central. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging The problem is that the CT finding alone cannot tell you which trajectory you are on. Two people with identical-looking low-attenuation livers can have very different prognoses depending on whether inflammation is present.
The practical takeaway is that the finding is a signal to investigate, not a sentence. A basic workup, including blood tests and potentially a FibroScan or MRI, can clarify whether you are dealing with harmless fat, early inflammation, or something that needs more aggressive attention. For the majority of people, the path forward involves the same metabolic housekeeping that benefits overall health anyway: managing weight, staying active, and controlling blood sugar and cholesterol. The liver, more so than most organs, has a remarkable capacity to heal when the insult driving the damage is removed.
Automated CT Analysis and Where the Field Is Heading
One reason this finding is showing up on more reports is that radiologists are getting better tools to spot it. Traditionally, measuring liver attenuation involved a radiologist manually placing a small circle (a region of interest) on the CT image and recording the HU value. This is time-consuming and somewhat subjective, since where exactly you place the circle affects the number. Newer automated methods using deep-learning algorithms can segment the entire liver and calculate attenuation across the whole organ, achieving excellent agreement with manual measurements.24PubMed Central. Fully automatic liver attenuation estimation combing CNN segmentation and morphological operations As these tools become standard, incidental fatty liver will likely be flagged even more consistently, turning every abdominal CT into a potential screening opportunity for a disease that affects a large fraction of the population but often goes undiagnosed until it has progressed.
Low liver attenuation on a CT scan, in other words, is not a diagnosis you need to fear but a data point you should act on. It puts you and your doctor in a position to catch a common, treatable condition early, often years before it would have caused symptoms on its own.